scholarly journals OESOPHAGEAL STENTING IN MALIGNANT DYSPHAGIA - FACTORS ASSOCIATED WITH DIFFERENT COMPLICATIONS AND THEIR EFFECT ON LONG-TERM PROGNOSIS

2016 ◽  
Vol 5 (101) ◽  
pp. 7413-7417
Author(s):  
Parvinder Singh ◽  
Ghansham Sharma ◽  
Abhitesh Singh ◽  
Anantbir Singh ◽  
Parmod Kumar Bhatia ◽  
...  
2019 ◽  
Vol 90 (7) ◽  
pp. 761-767 ◽  
Author(s):  
Loes Crielaard ◽  
Andrius Kavaliunas ◽  
Ryan Ramanujam ◽  
Tomas Olsson ◽  
Jan Hillert ◽  
...  

ObjectiveBenign multiple sclerosis (BMS) is often defined by the Expanded Disability Status Scale (EDSS) score of ≤3.0 after ≥15 years of disease duration. This classification’s clinical relevance remains unclear as benign patients may suffer other impairments and advance towards a progressive course, prompting our objective to holistically investigate factors associated with BMS and its long-term prognosis.MethodsBenign cases were identified in the Swedish Multiple Sclerosis registry. Baseline clinical data, demographic features and influence of multiple sclerosis (MS) major risk alleles on likelihood of benign course were investigated. Physical disability (EDSS), cognitive function (Symbol Digit Modalities Test; SDMT) and self-reported and socioeconomic differences between benign and non-benign patients were evaluated using generalised estimation equations models.Results11222 patients (2420 benign/8802 non-benign) were included. Benign patients were more likely to be female and younger at MS onset, have fewer relapses within the first two and 5 years from onset and fully recover from the first relapse (p<0.001). No association between human leucocyte antigen (HLA) DRB1*15:01 carriership (OR: 0.97, 95% CI: 0.86 to 1.09) or HLA-A*02:01 lacking (OR: 0.99, 95% CI: 0.87 to 1.11) and benign/non-benign was found. Non-benign patients accumulated an extra 0.04 (95% CI 0.03 to 0.04, p<0.001) EDSS score/year, lost an extra 0.3 (95% CI − 0.39 to − 0.18, p<0.001) SDMT score/year and deteriorated faster in self-reported impact and socioeconomic measures (p<0.001).ConclusionPatients with BMS have a better disease course as they progress more slowly at the group level in all respects. Lack of an association with major genetic risk factors indicates that MS course is most likely influenced by either environmental factor(s) or genetic factors outside the HLA region.


2017 ◽  
Vol 23 (34) ◽  
pp. 6212 ◽  
Author(s):  
Renate S Olsen ◽  
Johnny Nijm ◽  
Roland E Andersson ◽  
Jan Dimberg ◽  
Dick Wågsäter

1997 ◽  
Vol 10 (3) ◽  
pp. 165-175
Author(s):  
Nancy A. Letassy

Epidemiology of asthma is discussed in terms of the prevalence, risk factors associated with increasing morbidity and mortality, impact on life-style, long-term prognosis, and economic impact. Those most at risk for development of asthma are young children, African Americans, and those in lower economic status and inner-city communities. The primary contributing factor to increasing morbidity and mortality is undertreatment. Contributing factors may be restricted access to continuing medical care, unstable family situations, cultural and language barriers, failure to recognize severity of the disease, and inability to afford care.


2021 ◽  
Vol 10 (18) ◽  
pp. 4270
Author(s):  
Hack-Lyoung Kim ◽  
Sang-Ho Jo

Vasospastic angina (VSA) is characterized by a reversible spasm of the coronary arteries and is more prevalent in Asians. Vasodilators, such as calcium channel blockers, are effective in relieving coronary spasms and preventing clinical events. Therefore, the prognosis of VSA is generally known to be better than for significant organic stenosis caused by atherosclerosis. However, coronary vasospasm is sometimes associated with fatal complications such as sudden death, ventricular arrhythmia, and myocardial infarction. Thus, it is very important to identify and actively treat high-risk patients to prevent VSA complications. Here, we will review clinical factors associated with long-term prognosis in patients with VSA.


Infection ◽  
2010 ◽  
Vol 38 (6) ◽  
pp. 465-470 ◽  
Author(s):  
F. Hanses ◽  
C. Spaeth ◽  
B. P. Ehrenstein ◽  
H.-J. Linde ◽  
J. Schölmerich ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document